Perampanel exhibits anticonvulsant action against pentylentetrazol-induced seizures in immature rats
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
33296808
DOI
10.1016/j.eplepsyres.2020.106523
PII: S0920-1211(20)30574-X
Knihovny.cz E-zdroje
- Klíčová slova
- AMPA receptors, Pentylenetetrazol, Perampanel, Postnatal development, Rat,
- MeSH
- antikonvulziva farmakologie terapeutické užití MeSH
- krysa rodu Rattus MeSH
- nitrily MeSH
- pentylentetrazol toxicita MeSH
- potkani Wistar MeSH
- pyridony MeSH
- záchvaty * chemicky indukované farmakoterapie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antikonvulziva MeSH
- nitrily MeSH
- pentylentetrazol MeSH
- perampanel MeSH Prohlížeč
- pyridony MeSH
Perampanel is a new antiepileptic drug with unique mechanism of action - antagonism of AMPA receptors. Its action in immature animals is not yet sufficiently known therefore we started to study anticonvulsant action of perampanel pretreatment (1-20 mg/kg i.p.) against seizures elicited by pentylenetetrazol. Three age groups of rats were examined - 12, 18 and 25 days old. Perampanel selectively suppressed the tonic phase of generalized seizures in the two younger groups and whole tonic-clonic seizures in the 25-day-old group. It exhibited also an anticonvulsant action against minimal clonic seizures present in control 18- and 25-day-old rats. Perampanel is an effective anticonvulsant drug even at very early stages of brain development.
Citace poskytuje Crossref.org
